A fuel-price shock is pulling US buyers toward EVs just as Rivian's R2 widens its addressable market, and record deliveries show demand holding up without subsidies. At about 3.9x trailing revenue and 36% below the 52-week high, the shares price in a stumble on the Q4 R2 ramp.
Rivian is a battery electric vehicle automaker that sells its vehicles in the US and Canada. The company also develops electronic control units and related software for autos in a joint venture with Volkswagen. Rivian has multiple vehicles in its fleet, which include a luxury truck, a full-size SUV, and a delivery van. The company plans to begin selling…
www.rivian.com- 1Q3 2026 financial results, Oct 29 after market close (webcast at 5:00 p.m. ET): R2 gross profit trajectory, Q4 delivery commentary, any change to the EBITDA…
- 2Q4 and full-year 2026 delivery report, early January 2027: test of the 65,000-70,000 guide, which needs at least 23,193 in Q4.
- 3R2 Premium ($53,990) launch in late 2026 and R2 Standard Long Range ($48,490) in early 2027, which widen the fuel-sensitive buyer pool.
- 4Autonomy+ point-to-point rollout, expected by the end of this year.
- 5EIA STEO on Nov 10 and weekly AAA/EIA fuel data: the read-through on how long pump prices stay elevated.
- 1R2 ramp execution: Citi initiated at Neutral with an $18 target on ramp concerns, and the CEO said supply chain, not the factory, is the bottleneck (per Stoc…
- 2Oil tailwind may fade: EIA expects Brent at $84 in 2027, and one source puts a durable Hormuz reopening at roughly $65-90. Buyer response to fuel prices is n…
- 3Still deeply loss-making: Q2 net loss was $837 million, FY adjusted EBITDA loss guidance is $1.8-2.0 billion, and capex is $1.7-1.8 billion. Further dilution…
- 4Premium pricing: R2 is sold only in the roughly $58,000 Performance trim, and the sub-$50,000 trims are not due until 2027. Per Automotive World, Q3 shows de…
- 5Sell-side is split: JPM (Sell, $15) and Morgan Stanley (Sell, $14) cite capital intensity and valuation, and consensus is Hold.
Read the Full Thesis
- Oct 13, 2026 · Price 13.54
Weekly check-in: On Track. No earnings or guide change yet; funding eased, R2 execution flags and price weakness The next hard test is the Oct 29 Q3 release, so the thesis evidence is largely unchanged this week. The $1B Volkswagen loan reduces near-term capital-raise risk, which supports must-be-true point 3. Against that, the R2 ramp-execution risk showed more signs of strain, and the shares have drifted lower, toward the 12.3 stop. Nothing in the week confirms or breaks the 23,000+ Q4 requirement.
- Oct 20, 2026 · Price 12.23
Weekly check-in: Weakened. Shares broke below the stop level; memory-chip cost hits R2 margin case No earnings or guidance change yet, but the evidence leaned against the thesis this week. Per the CEO, memory-chip prices add many hundreds of dollars to each vehicle. That lands on the R2 gross-profit-positive-by-year-end leg, and the supply-side risk the case flags is showing up in costs as well as volume. Shares touched about 12.16 on Oct 19, a 14-month low, below both the 12.3 stop and the 12.39 52-week low cited in the case. Q3 results on Oct 29 now carry more weight.
1 published revision. Performance is measured from the original publication, not from any revision.
- Revision 1 · Oct 20, 2026, 8:24 PM UTC
“Updated target and stop price.”
- Price Target$19.23→$21.23
- Stop$12.30→$10.30
- Originally published Oct 7, 2026, 7:55 PM UTC.
Disagree? Make the opposite case with your own levels. Both get scored, so the debate gets a winner.
Copy it into your own account, adjust it to your view, and get an alert when the price reaches its levels.